Table of Contents

Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease linked to repetitive head impacts, most notably among athletes in contact sports, military veterans exposed to blast waves, and individuals with a history of recurrent concussions. For decades, CTE could only be diagnosed after death through post-mortem brain examination. However, advances in Magnetic Resonance Imaging (MRI) are transforming the landscape by enabling researchers and clinicians to detect structural and microstructural brain changes associated with CTE in living patients. This article provides an in-depth exploration of how MRI is being used to detect, monitor, and manage CTE, while examining the strengths, limitations, and future potential of this imaging modality.

Understanding Chronic Traumatic Encephalopathy (CTE)

Pathophysiology of CTE

CTE is characterized by the abnormal accumulation of hyperphosphorylated tau protein, which forms neurofibrillary tangles and aggregates primarily in the sulcal depths of the cerebral cortex. This tau pathology is distinct from Alzheimer’s disease and other tauopathies in its distribution and morphology. Repeated head trauma triggers a cascade of neuroinflammatory responses, axonal injury, and blood–brain barrier disruption, leading to progressive neurodegeneration. Over time, the build‑up of tau spreads to the frontal and temporal lobes, limbic system, and deep brain structures, causing neuronal loss, brain atrophy, and enlargement of the ventricles.

Epidemiology and Risk Groups

The true prevalence of CTE remains unknown, but it is most strongly associated with contact sports such as American football, boxing, ice hockey, rugby, and soccer. Military personnel exposed to blast‑induced traumatic brain injury (TBI) are also at elevated risk. A landmark study of 202 deceased former American football players found CTE pathology in 87% of those with a history of repetitive head impacts. Younger individuals involved in combat sports or with prolonged athletic careers likewise show early‑stage changes. Post‑mortem series underscore that CTE is not exclusive to elite athletes — it can affect anyone with cumulative head trauma, including victims of physical abuse and individuals with seizure disorders.

The Clinical Challenge of Diagnosing CTE in Living Patients

Current Diagnostic Criteria

In vivo diagnosis of CTE remains difficult because symptoms — memory loss, executive dysfunction, mood instability, impulsivity, and motor impairment — overlap with other neurodegenerative diseases, psychiatric conditions, and the effects of normal aging. The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) have proposed clinical diagnostic criteria for traumatic encephalopathy syndrome, but these rely heavily on history of head trauma and ruling out alternative causes. The definitive diagnosis still requires brain tissue analysis, making imaging biomarkers an urgent priority.

The Role of Imaging Biomarkers

Imaging biomarkers are objective, measurable indicators of pathological changes that can be visualized with medical imaging. For CTE, these include patterns of brain atrophy, white matter integrity loss, iron deposition, and subtle microstructural damage. MRI, with its high spatial resolution and ability to probe multiple tissue properties, is the leading non‑invasive modality to detect such biomarkers. Researchers hope that a combination of MRI findings, clinical history, and emerging fluid biomarkers (e.g., serum tau and neurofilament light) will eventually allow accurate antemortem diagnosis.

MRI Techniques for CTE Detection

Structural MRI: Atrophy Patterns and Ventricular Enlargement

Standard T1‑weighted MRI provides high‑resolution anatomical images that allow volumetric analysis of brain structures. In CTE, the most consistently reported structural changes include:

  • Cortical atrophy, particularly in the frontal lobes, anterior temporal lobes, and cingulate gyrus.
  • Enlarged lateral ventricles, reflecting loss of surrounding brain parenchyma.
  • Cavum septum pellucidum — a remnant of the septal leaves that is more common and often fenestrated in those with repetitive head trauma.

While these findings are not specific to CTE — they also occur in Alzheimer’s disease, frontotemporal dementia, and normal aging — their combination with a history of head impacts raises suspicion. Techniques such as automated segmentation (e.g., FreeSurfer) can quantify regional atrophy with greater precision.

Diffusion Tensor Imaging (DTI) and White Matter Integrity

Diffusion Tensor Imaging (DTI) measures the diffusion of water molecules within brain tissue, providing insight into white matter microstructure. In CTE, damage to axons and myelin leads to decreased fractional anisotropy (FA) and increased mean diffusivity (MD) in key tracts such as the corpus callosum, fornix, uncinate fasciculus, and superior longitudinal fasciculus. These changes can be detected even in living patients who are still asymptomatic, making DTI a promising early marker. However, DTI results have been inconsistent across studies due to variations in protocols, participant demographics, and threshold for head trauma exposure.

Susceptibility‑Weighted Imaging (SWI) for Microbleeds

SWI is a gradient‑echo MRI sequence that is exquisitely sensitive to hemosiderin, a breakdown product of blood. It can detect microbleeds and traumatic microhemorrhages that persist long after the acute injury. In CTE, SWI shows a higher burden of microbleeds, especially in the corpus callosum, brainstem, and juxtacortical white matter. These findings suggest chronic blood‑brain barrier disruption and ongoing vascular damage, which may contribute to tau deposition and neurodegeneration.

Magnetic Resonance Spectroscopy (MRS) for Metabolic Changes

MRS provides a metabolic profile of brain tissue by measuring concentrations of metabolites such as N‑acetylaspartate (NAA, a marker of neuronal health), choline (membrane turnover), creatine, and lactate. In CTE‑affected regions, MRS can reveal reduced NAA, elevated choline, and increased lactate, indicating neuronal loss, gliosis, and metabolic stress. While MRS is less widely used due to technical demands and longer acquisition times, it offers complementary information that could help differentiate CTE from other pathologies.

Advanced Techniques: Quantitative Susceptibility Mapping and Resting‑State fMRI

Quantitative susceptibility mapping (QSM) goes beyond SWI by providing voxel‑wise maps of magnetic susceptibility, allowing quantification of iron deposition and calcification. Elevated iron in the basal ganglia and deep grey matter has been linked to both aging and repeated head trauma, and QSM may help track these changes over time. Resting‑state functional MRI (rs‑fMRI) evaluates intrinsic brain connectivity networks. Disruption of the default mode network and fronto‑parietal networks has been observed in individuals at risk for CTE, potentially reflecting early functional deficits before structural atrophy is visible.

MRI Findings in CTE: A Review of Key Studies

Frontal and Temporal Lobe Atrophy

Several case‑control and cross‑sectional studies have demonstrated reduced volumes in the orbitofrontal cortex, dorsolateral prefrontal cortex, and anterior temporal lobes in living individuals with a history of repetitive head trauma. A study involving living former NFL players found that those with higher exposure had greater atrophy in the hippocampus and amygdala, correlating with memory and mood symptoms. Importantly, volumetric loss appears to progress over years, and MRI can track this trajectory.

Cingulate Gyrus and Corpus Callosum Involvement

The cingulate gyrus is particularly vulnerable in CTE, with both thinning and reduced fractional anisotropy reported. The corpus callosum — the large white‑matter bridge connecting hemispheres — often shows microstructural damage, especially in the genu and splenium. Researchers using DTI have reported lower FA in the corpus callosum of fighters and football players compared with controls, and these changes correlate with cumulative head impact exposure.

Disruption of White Matter Tracts

Beyond the corpus callosum, the fornix (critical for memory), uncinate fasciculus (linking temporal and frontal lobes), and superior longitudinal fasciculus (involved in language) show altered diffusion metrics. Tract‑based spatial statistics (TBSS) analyses have revealed widespread white matter disruption in combat sports athletes. These findings suggest that MRI can capture the network‑level damage that underlies cognitive and behavioral symptoms.

Comparing MRI with Other Neuroimaging Modalities

Positron Emission Tomography (PET) for Tau Imaging

PET scans using tau‑targeted radioligands (e.g., flortaucipir, [18F]MK‑6240) allow direct visualization of tau aggregates in the brain. While tau PET has shown promise for detecting the signature pattern of CTE — especially in the superior frontal sulci and medial temporal lobe — it is costly, involves ionizing radiation, and is not routinely available. Moreover, the current tracers have greater affinity for Alzheimer‑type tau than for the paired helical filaments of CTE, limiting sensitivity. MRI, by contrast, is widely available, radiation‑free, and can capture multiple aspects of brain structure and function in a single session.

CT and its Limitations

Computed tomography (CT) is the standard first‑line imaging in acute head trauma due to its speed and sensitivity to intracranial hemorrhage. However, CT lacks the soft‑tissue contrast to detect subtle atrophy, white‑matter changes, or microbleeds associated with CTE. Its role is essentially limited to rule‑out of acute surgical lesions.

MRI as the Preferred First‑Line Imaging

Given its versatility, safety, and high resolution, MRI has become the preferred imaging modality for evaluating living individuals with suspected CTE. The American Academy of Neurology and the NINDS recommend structural MRI as part of the diagnostic workup for traumatic encephalopathy syndrome. While no single MRI sequence is diagnostic, a multimodal protocol combining T1, T2, DTI, SWI, and possibly MRS provides the most comprehensive picture.

Managing CTE with MRI‑Based Insights

Early Detection and Cognitive Rehabilitation

Identifying brain changes before symptoms become severe allows earlier implementation of cognitive rehabilitation strategies, including memory training, executive function exercises, and compensatory techniques. MRI findings of hippocampal atrophy or fornix damage can alert clinicians to prioritize memory‑focused interventions. Early detection also enables patient and family education about the nature of the disease and the importance of avoiding further head impacts.

Monitoring Disease Progression over Time

Serial MRI — typically performed annually or biennially — enables tracking of atrophy rates, DTI changes, and accumulation of microbleeds. This information helps clinicians tailor management and assess whether interventions such as lifestyle modifications, medications, or experimental treatments are modifying the disease course. In research settings, MRI‑derived metrics serve as surrogate endpoints in clinical trials.

Informing Lifestyle and Activity Modifications

Visible structural damage can motivate patients to reduce exposure to repetitive head trauma. For athletes, MRI evidence of brain changes may prompt decisions to retire from contact sports earlier than planned. For military personnel, it can influence deployment and training modifications. Counseling based on objective imaging data often carries more weight than subjective symptoms alone.

Role in Clinical Trials and Treatment Development

MRI is increasingly used as an inclusion criterion and outcome measure in trials for potential CTE therapies. For example, a trial testing an anti‑tau antibody may enroll participants who show DTI abnormalities or atrophy in characteristic regions, and then measure changes in those imaging biomarkers over the study period. This accelerates drug development by providing quantitative, objective endpoints.

Limitations and Challenges of MRI in CTE

Lack of Specificity and Overlap with Other Neurodegenerative Diseases

Atrophy patterns and white‑matter changes in CTE overlap considerably with Alzheimer’s disease, frontotemporal dementia, Lewy body disease, and even chronic traumatic brain injury without CTE. No single MRI finding is pathognomonic, and misclassification remains a risk. The field is working toward developing composite imaging signatures and combining MRI with tau PET or fluid biomarkers to improve specificity.

Need for Standardized Protocols and Larger Studies

Much of the existing MRI research on CTE involves small sample sizes, cross‑sectional designs, and heterogeneous imaging protocols. To establish robust diagnostic criteria, multi‑center longitudinal studies with harmonized acquisition parameters are needed. The NIH’s Parkinson’s Disease Biomarkers Program and the DIAGNOSE CTE Research Project represent important steps forward, but more large‑scale efforts are required.

Cost and Accessibility

Advanced MRI sequences (DTI, SWI, MRS, QSM) are not universally available and require specialized expertise for acquisition and analysis. Costs can be prohibitive, especially for serial imaging. As technology matures and sequences become part of standard brain MRI protocols — such as the inclusion of SWI in many commercial packages — accessibility may improve.

Future Directions in MRI Research for CTE

Artificial Intelligence and Automated Analysis

Machine learning algorithms can analyze high‑dimensional MRI data to identify patterns invisible to the human eye. Deep learning models trained on large datasets may eventually predict CTE pathology from scans with high accuracy. Automated segmentation and classification tools could reduce inter‑rater variability and enable widespread screening.

Longitudinal Imaging Studies

Critical questions about CTE — such as the time between head‑impact exposure and appearance of MRI changes, the rate of progression, and whether some individuals are resilient — require longitudinal studies following at‑risk cohorts over decades. Several ongoing projects, such as the Long‑Term Impact of Repeated Mild Traumatic Brain Injury in Contact Sports study, are poised to provide answers.

Integration with Blood Biomarkers and Genetics

Combining MRI data with blood‑based biomarkers (e.g., neurofilament light, glial fibrillary acidic protein, phosphorylated tau 181) and genetic risk factors (e.g., APOE ε4, MAPT haplotypes) could dramatically improve diagnostic accuracy. A multi‑modal approach would allow early detection, subtyping of disease, and personalized treatment plans.

Conclusion

Magnetic Resonance Imaging has emerged as an indispensable tool in the fight against Chronic Traumatic Encephalopathy. While the disease remains a diagnosis of exclusion during life, MRI provides a window into the structural and microstructural damage caused by repetitive head impacts. From atrophy patterns and white‑matter disruption to microbleeds and metabolic changes, modern MRI techniques offer a multi‑faceted view of CTE pathology. The integration of MRI with clinical history, emerging biomarkers, and advanced analytics holds the promise of earlier and more accurate diagnosis, better monitoring of disease progression, and the development of effective therapies. Despite current limitations — including lack of specificity, standardization gaps, and cost — ongoing research and technological advances continue to push the boundaries of what MRI can achieve in the context of CTE. For patients at risk, and for the clinicians who care for them, MRI remains a key ally in understanding and managing this devastating condition.

National Institute of Neurological Disorders and Stroke – CTE Information

Multimodal MRI in CTE: A Review

American Academy of Neurology – Concussion Guidelines

JAMA – Tau PET and MRI in CTE

Diffusion Tensor Imaging in Repetitive Head Trauma